State Street’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.18M | Buy |
372,806
+286,125
| +330% | +$3.21M | ﹤0.01% | 3023 |
|
2025
Q1 | $889K | Buy |
86,681
+61,658
| +246% | +$633K | ﹤0.01% | 3458 |
|
2024
Q4 | $485K | Buy |
+25,023
| New | +$485K | ﹤0.01% | 3624 |
|
2024
Q3 | – | Sell |
-4,976
| Closed | -$229K | – | 4349 |
|
2024
Q2 | $229K | Hold |
4,976
| – | – | ﹤0.01% | 3780 |
|
2024
Q1 | $106K | Sell |
4,976
-952
| -16% | -$20.3K | ﹤0.01% | 4024 |
|
2023
Q4 | $121K | Hold |
5,928
| – | – | ﹤0.01% | 4019 |
|
2023
Q3 | $143K | Sell |
5,928
-42
| -0.7% | -$1.01K | ﹤0.01% | 4022 |
|
2023
Q2 | $145K | Hold |
5,970
| – | – | ﹤0.01% | 4107 |
|
2023
Q1 | $143K | Hold |
5,970
| – | – | ﹤0.01% | 4187 |
|
2022
Q4 | $169K | Hold |
5,970
| – | – | ﹤0.01% | 4172 |
|
2022
Q3 | $148K | Hold |
5,970
| – | – | ﹤0.01% | 4271 |
|
2022
Q2 | $178K | Buy |
5,970
+142
| +2% | +$4.23K | ﹤0.01% | 4265 |
|
2022
Q1 | $161K | Hold |
5,828
| – | – | ﹤0.01% | 4462 |
|
2021
Q4 | $150K | Hold |
5,828
| – | – | ﹤0.01% | 4459 |
|
2021
Q3 | $207K | Buy |
5,828
+75
| +1% | +$2.66K | ﹤0.01% | 4346 |
|
2021
Q2 | $241K | Buy |
+5,753
| New | +$241K | ﹤0.01% | 4144 |
|